- Advanced search
- Immuno Portal
- Malaria Portal
acipimox is an approved drug (UK (2003))
Compound class: Synthetic organic
Comment: Acipimox is a nicotinic acid derivative.
Ligand Activity Visualisation Charts
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
View more information in the IUPHAR Pharmacology Education Project: acipimox
1. Soga T, Kamohara M, Takasaki J, Matsumoto S, Saito T, Ohishi T, Hiyama H, Matsuo A, Matsushime H, Furuichi K. (2003)
Molecular identification of nicotinic acid receptor.
Biochem Biophys Res Commun, 303 (1): 364-9. [PMID:12646212]
2. Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, Ignar DM, Murdock PR, Steplewski K, Green A et al.. (2003)
Molecular identification of high and low affinity receptors for nicotinic acid.
J Biol Chem, 278 (11): 9869-74. [PMID:12522134]